/newsroom/taxonomy/term/8810/all en /newsroom/channels/news/experts-fda-approves-much-debated-alzheimers-drug-panned-experts-331414 <p>U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (<a href="https://www.ctvnews.ca/health/fda-approves-much-debated-alzheimer-s-drug-panned-by-experts-1.5459470" target="_blank">CTV News</a>)</p> Tue, 08 Jun 2021 20:48:35 +0000 frederique.mazerolle@mcgill.ca 269362 at /newsroom /newsroom/gerhard-multhaup Thu, 05 Aug 2021 19:58:18 +0000 frederique.mazerolle@mcgill.ca 271819 at /newsroom /newsroom/simon-ducharme Thu, 05 Aug 2021 19:47:04 +0000 frederique.mazerolle@mcgill.ca 271817 at /newsroom /newsroom/maiya-geddes Tue, 15 Dec 2020 21:25:28 +0000 frederique.mazerolle@mcgill.ca 253355 at /newsroom /newsroom/channels/news/mcgill-researchers-identify-correlation-between-mild-behavioural-impairment-and-alzheimers-321513 <p>New research from McGill University has found that the presence and severity of mild behavioural impairment (MBI) in cognitively healthy individuals is strongly associated with the presence of amyloid plaques deposits in the brain, a hallmark of Alzheimer’s disease.</p> Wed, 08 Apr 2020 17:21:43 +0000 frederique.mazerolle@mcgill.ca 207272 at /newsroom /newsroom/channels/news/mcgill-study-identifies-new-role-major-genetic-risk-factor-alzheimers-disease-303726 <p>For years, physicians have been aware that patients carrying the apolipoprotein ꜫ4 (APOE <i>ꜫ4</i>) gene are at a greater risk of developing Alzheimer’s disease. New research from McGill University has now found the gene plays an even greater role in dementia.<br /> <br /></p> Fri, 20 Dec 2019 14:57:15 +0000 frederique.mazerolle@mcgill.ca 191700 at /newsroom /newsroom/channels/news/ai-could-predict-cognitive-decline-leading-alzheimers-disease-next-5-years-290378 <p>A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer’s disease.</p> Thu, 04 Oct 2018 15:16:31 +0000 priya.pajel@mail.mcgill.ca 86748 at /newsroom /newsroom/channels/news/new-mechanism-detected-alzheimers-disease-276135 <p><em>By Chris Chipello</em></p> <p>McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.</p> Thu, 12 Oct 2017 17:02:42 +0000 priya.pajel@mail.mcgill.ca 32382 at /newsroom /newsroom/channels/news/could-olfactory-loss-point-alzheimers-disease-269504 <p>By the time you start losing your memory, it's almost too late. That's because the damage to your brain associated with Alzheimer’s disease (AD) may already have been going on for as long as twenty years. Which is why there is so much scientific interest in finding ways to detect the presence of the disease early on. Scientists now believe that simple odour identification tests may help track the progression of the disease before symptoms actually appear, particularly among those at risk.</p> Tue, 15 Aug 2017 16:26:14 +0000 priya.pajel@mail.mcgill.ca 32169 at /newsroom /newsroom/edith-hamel Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22916 at /newsroom